**Question:** In children with cerebral oedema which one of the following corticosteroids will be effective –

A. Dexamethasone
B. Hydrocortisone
C. Prednisolone
D. Prednisone

**Core Concept:**
Corticosteroids are a class of hormones that have anti-inflammatory, immunosuppressive, and anti-proliferative effects. They act by binding to intracellular glucocorticoid receptors, leading to gene transcription and subsequent protein synthesis.

**Why the Correct Answer is Right:**
Dexamethasone is a potent synthetic glucocorticoid with a long half-life (approximately 36-72 hours). Its high affinity for glucocorticoid receptors and low affinity for mineralocorticoid receptors make it a suitable choice for treating cerebral oedema, a condition characterized by increased brain water content due to impaired cerebral blood flow, increased capillary permeability, and inflammation. In cerebral oedema, a glucocorticoid with a long half-life is preferred to maintain a therapeutic effect over an extended period.

**Why Each Wrong Option is Ineffective:**

**Option A (Dexamethasone):** This option is correct and does not require further explanation.

**Option B (Hydrocortisone):** Hydrocortisone is a natural glucocorticoid with a shorter half-life (approximately 2-3 hours). Its rapid clearance and shorter half-life make it less effective in maintaining a therapeutic effect over an extended period for cerebral oedema management.

**Option C (Prednisolone):** Prednisolone is another synthetic glucocorticoid with a similar half-life to hydrocortisone (approximately 2-3 hours). Similar to hydrocortisone, its shorter half-life makes it less effective in managing cerebral oedema.

**Option D (Prednisone):** Prednisone is a prodrug of prednisolone that requires enzymatic conversion (by the enzyme 11β-hydroxysteroid dehydrogenase) to its active form, prednisolone. Although prednisone is effective as a prodrug, it is less effective than dexamethasone, which is a direct active glucocorticoid.

**Clinical Pearls:**
In therapeutic decision-making for cerebral oedema treatment, the choice of corticosteroid should consider the drug's half-life, as a drug with a longer half-life (like dexamethasone) is preferred for its sustained therapeutic effect on cerebral oedema.

**Why Dexamethasone is the Best Choice:**
Dexamethasone has a long half-life (approximately 36-72 hours) which allows for a sustained therapeutic effect in treating cerebral oedema. This ensures that cerebral blood flow is maintained and reduced inflammation in the brain, thus minimizing neurological complications associated with cerebral oedema.